000 01682 a2200493 4500
005 20250514205916.0
264 0 _c20050628
008 200506s 0 0 eng d
022 _a0959-4973
024 7 _a10.1097/00001813-200411000-00009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAppleyard, Virginia C L
245 0 0 _aActivity of MDI-301, a novel synthetic retinoid, in xenografts.
_h[electronic resource]
260 _bAnti-cancer drugs
_cNov 2004
300 _a991-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAlitretinoin
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBreast Neoplasms
650 0 4 _aCell Line, Tumor
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aProstatic Neoplasms
650 0 4 _aReceptors, Retinoic Acid
_xbiosynthesis
650 0 4 _aRetinoic Acid Receptor alpha
650 0 4 _aRetinoids
_xpharmacology
650 0 4 _aTretinoin
_xpharmacology
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aO'Neill, Mary A
700 1 _aMurray, Karen E
700 1 _aBray, Susan E
700 1 _aThomson, George
700 1 _aKernohan, Neil M
700 1 _aVarani, James
700 1 _aZhang, Jian
700 1 _aThompson, Alastair M
773 0 _tAnti-cancer drugs
_gvol. 15
_gno. 10
_gp. 991-6
856 4 0 _uhttps://doi.org/10.1097/00001813-200411000-00009
_zAvailable from publisher's website
999 _c15203012
_d15203012